These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 36208904)
1. Parkinson's disease and Covid-19: The effect and use of telemedicine. Podlewska AM; van Wamelen DJ Int Rev Neurobiol; 2022; 165():263-281. PubMed ID: 36208904 [TBL] [Abstract][Full Text] [Related]
2. A French survey on the lockdown consequences of COVID-19 pandemic in Parkinson's disease. The ERCOPARK study. Fabbri M; Leung C; Baille G; Béreau M; Brefel Courbon C; Castelnovo G; Carriere N; Damier P; Defebvre L; Doe de Maindreville A; Fluchere F; Fuzzatti M; Grabli D; Maltete D; Rousseau V; Sommet A A; Thalamas C; Thiriez C; Rascol O; Ory-Magne F Parkinsonism Relat Disord; 2021 Aug; 89():128-133. PubMed ID: 34293534 [TBL] [Abstract][Full Text] [Related]
3. Movement disorders in COVID-19 times: impact on care in movement disorders and Parkinson disease. Poonja S; Chaudhuri KR; Miyasaki JM Curr Opin Neurol; 2022 Aug; 35(4):494-501. PubMed ID: 35787539 [TBL] [Abstract][Full Text] [Related]
4. Implementation of Telemedicine for Urgent and Ongoing Healthcare for Patients with Parkinson's Disease During the COVID-19 Pandemic: New Expectations for the Future. Cubo E; Hassan A; Bloem BR; Mari Z; J Parkinsons Dis; 2020; 10(3):911-913. PubMed ID: 32417800 [No Abstract] [Full Text] [Related]
5. Promoting Physical Activity via Telehealth in People With Parkinson Disease: The Path Forward After the COVID-19 Pandemic? Quinn L; Macpherson C; Long K; Shah H Phys Ther; 2020 Sep; 100(10):1730-1736. PubMed ID: 32734298 [TBL] [Abstract][Full Text] [Related]
6. The impact of COVID-19 on palliative care for people with Parkinson's and response to future pandemics. Chaudhuri KR; Rukavina K; McConvey V; Antonini A; Lorenzl S; Bhidayasiri R; Piemonte MEP; Lim SY; Richfield E; Walker R; Bouca-Machado R; Bajwah S; Gao W; Trivedi D; Miyasaki J Expert Rev Neurother; 2021 Jun; 21(6):615-623. PubMed ID: 33905283 [No Abstract] [Full Text] [Related]
7. [The questionnaire survey regarding the impact of COVID-19 pandemic on Parkinson's disease patients]. Tezuka T; Osada T; Terayama Y; Kubota M; Okusa S; Shiihashi G; Kubo SI; Suzuki N; Nakahara J; Seki M Rinsho Shinkeigaku; 2022 Jan; 62(1):8-14. PubMed ID: 34924470 [TBL] [Abstract][Full Text] [Related]
8. Covid-19 and Parkinson's disease: Acute clinical implications, long-COVID and post-COVID-19 parkinsonism. Leta V; Boura I; van Wamelen DJ; Rodriguez-Violante M; Antonini A; Chaudhuri KR Int Rev Neurobiol; 2022; 165():63-89. PubMed ID: 36208907 [TBL] [Abstract][Full Text] [Related]
9. Telemedicine in Parkinson's Disease: How to Ensure Patient Needs and Continuity of Care at the Time of COVID-19 Pandemic. Miele G; Straccia G; Moccia M; Leocani L; Tedeschi G; Bonavita S; Lavorgna L; Telemed J E Health; 2020 Dec; 26(12):1533-1536. PubMed ID: 32667839 [No Abstract] [Full Text] [Related]
10. Feasibility, Reliability, and Value of Remote Video-Based Trial Visits in Parkinson's Disease. Tarolli CG; Andrzejewski K; Zimmerman GA; Bull M; Goldenthal S; Auinger P; O'Brien M; Dorsey ER; Biglan K; Simuni T J Parkinsons Dis; 2020; 10(4):1779-1786. PubMed ID: 32894251 [TBL] [Abstract][Full Text] [Related]
11. Lockdown effects on Parkinson's disease during COVID-19 pandemic: a pilot study. Falla M; Dodich A; Papagno C; Gober A; Narduzzi P; Pierotti E; Falk M; Zappini F; Colosimo C; Turella L Acta Neurol Belg; 2021 Oct; 121(5):1191-1198. PubMed ID: 34212285 [TBL] [Abstract][Full Text] [Related]
12. A New Day: The Role of Telemedicine in Reshaping Care for Persons With Movement Disorders. Dorsey ER; Bloem BR; Okun MS Mov Disord; 2020 Nov; 35(11):1897-1902. PubMed ID: 32870517 [TBL] [Abstract][Full Text] [Related]
13. Impact of Covid-19 on research and training in Parkinson's disease. Wan YM; van Wamelen DJ; Lau YH; Rota S; Tan EK Int Rev Neurobiol; 2022; 165():283-305. PubMed ID: 36208905 [TBL] [Abstract][Full Text] [Related]
14. Best practice approaches to outpatient management of people living with Parkinson's disease during the COVID-19 pandemic. Demleitner AF; Wolff AW; Erber J; Gebhardt F; Westenberg E; Winkler AS; Kolbe-Busch S; Chaberny IF; Lingor P J Neural Transm (Vienna); 2022 Nov; 129(11):1377-1385. PubMed ID: 35244753 [TBL] [Abstract][Full Text] [Related]
15. Parkinson's disease patients' perspective on telephone visits during the COVID-19 pandemic. Magriço M; Serôdio M; Ventura R; Bugalho P J Neural Transm (Vienna); 2023 Dec; 130(12):1547-1551. PubMed ID: 37709927 [TBL] [Abstract][Full Text] [Related]
16. Accurate Monitoring of Parkinson's Disease Symptoms With a Wearable Device During COVID-19 Pandemic. Tsamis KI; Rigas G; Nikolaos K; Fotiadis DI; Konitsiotis S In Vivo; 2021; 35(4):2327-2330. PubMed ID: 34182513 [TBL] [Abstract][Full Text] [Related]
17. Transition and Sustainability of an Online Care Model for People With Parkinson's Disease in Response to the COVID-19 Pandemic. Ketigian L; Piniella N; McGivney K; Lui S; Dukat A; Jung MK; Gallagher R; Leder A Front Public Health; 2021; 9():772805. PubMed ID: 35186865 [TBL] [Abstract][Full Text] [Related]
18. Care, Convenience, Comfort, Confidentiality, and Contagion: The 5 C's that Will Shape the Future of Telemedicine. Dorsey ER; Okun MS; Bloem BR J Parkinsons Dis; 2020; 10(3):893-897. PubMed ID: 32538870 [TBL] [Abstract][Full Text] [Related]
19. Stay mindfully active during the coronavirus pandemic: a feasibility study of mHealth-delivered mindfulness yoga program for people with Parkinson's disease. Kwok JYY; Lee JJ; Choi EPH; Chau PH; Auyeung M BMC Complement Med Ther; 2022 Feb; 22(1):37. PubMed ID: 35130894 [TBL] [Abstract][Full Text] [Related]
20. The Technological Impact of COVID-19 on the Future of Education and Health Care Delivery. Shah S; Diwan S; Kohan L; Rosenblum D; Gharibo C; Soin A; Sulindro A; Nguyen Q; Provenzano DA Pain Physician; 2020 Aug; 23(4S):S367-S380. PubMed ID: 32942794 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]